Age alone is not a risk factor for left atrial thrombus in atrial fibrillation

被引:9
作者
Mazouz, B. [2 ]
Keren, A. [2 ]
Chenzbraun, A. [1 ,2 ]
机构
[1] Royal Liverpool Hosp, Liverpool L7 8XP, Merseyside, England
[2] Bikur Cholim Hosp, Dept Cardiol, Jerusalem, Israel
关键词
D O I
10.1136/hrt.2006.110502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Advanced age is an indication for anticoagulation in patients with atrial fibrillation though it is not clear that elderly patients have a higher prevalence of left atrial thrombus. The purpose of this study was to clarify whether advanced age represents a risk for left atrial thrombus formation irrespective of other clinical variables. Design: Observational study in patients with atrial fibrillation undergoing a transoesophageal echo scan for various clinical indications. Setting: University- affiliated cardiology service in a general hospital. Patients: Results are reported in 381 patients, 257 aged less than 75 years (Gr. A) and 124 aged 75 years or more (Gr. B). Results: Thrombi were detected by TOE in 30 patients (7.9%), 21 from group A and nine from group B (8.1% vs 7.2%, p= NS). No thrombi were detected in patients with lone atrial fibrillation. Among patients with either valvular or nonvalvular atrial fibrillation, left atrial thrombus presence was not related to age or anticoagulation status. Conclusions: In patients with atrial fibrillation, age itself does not predict the presence of left atrial thrombus and the only identifiable risk factor seems to be the existing cardiac pathology.
引用
收藏
页码:197 / 199
页数:3
相关论文
共 18 条
[1]   Association of atrial fibrillation and aortic atherosclerosis: A population-based study [J].
Agmon, Y ;
Khandheria, BK ;
Meissner, I ;
Schwartz, GL ;
Petterson, TM ;
O'Fallon, WM ;
Gentile, F ;
Spittell, PC ;
Whisnant, JP ;
Wiebers, DO ;
Covalt, JL ;
Seward, JB .
MAYO CLINIC PROCEEDINGS, 2001, 76 (03) :252-259
[2]   Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin [J].
Beyth, RJ ;
Quinn, LM ;
Landefeld, CS .
AMERICAN JOURNAL OF MEDICINE, 1998, 105 (02) :91-99
[3]   Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care [J].
DeWilde, S. ;
Carey, I. M. ;
Emmas, C. ;
Richards, N. ;
Cook, D. G. .
HEART, 2006, 92 (08) :1064-1070
[4]   Mobile aortic atheroma and systemic emboli: Efficacy of anticoagulation and influence of plaque morphology on recurrent stroke [J].
Dressler, FA ;
Craig, WR ;
Castello, R ;
Labovitz, AJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (01) :134-138
[5]   Major bleeding during anticoagulation after cerebral ischemia - Patterns and risk factors [J].
Gorter, JW .
NEUROLOGY, 1999, 53 (06) :1319-1327
[6]   Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation - The AFASAK 2 Study [J].
Gullov, AL ;
Koefoed, BG ;
Petersen, P .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (12) :1322-1328
[7]   Lessons from the Stroke Prevention in Atrial Fibrillation trials [J].
Hart, RG ;
Halperin, JL ;
Pearce, LA ;
Anderson, DC ;
Kronmal, RA ;
McBride, R ;
Nasco, E ;
Sherman, DG ;
Talbert, RL ;
Marler, JR .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) :831-838
[8]   Safe introduction of warfarin for thrombotic prophylaxis in atrial fibrillation requiring only a weekly INR [J].
Janes, S ;
Challis, R ;
Fisher, F .
CLINICAL AND LABORATORY HAEMATOLOGY, 2004, 26 (01) :43-47
[9]  
LANDEFELD CS, 1989, AM J MED, V87, P144
[10]  
LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449